← All stocks

Cabaletta Bio, Inc.

CABA No buying or selling
CIK 0001759138 #3036 in the set updated 19 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

8 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Nichtberger Steven
President & CEO
1,031,483
$2.34M
+4.6%
Simon Mark
Director
147,205
$334.10K
+8.1%
Binder Gwendolyn
President, Science & Tech.
31,312
$71.07K
+56.6%
Tomasello Shawn
Director
22,725
$51.58K
Gavel Steve
Chief Commercial Officer
22,170
$50.32K
Chang David J.
Chief Medical Officer
8,800
$19.97K
Gerard Michael
General Counsel
6,600
$14.98K
Bollard Catherine
Director
5,405
$12.27K
+440.5%

No percentages here. This company's share count has moved by a factor of 3.5 over the window, from 48,877,164 to 169,545,445 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 28 Oct 2019